US CMS described several products winning device pass-through payment status for 2021 in an outpatient prospective payment system final rule.
An artificial iris, single-use duodenoscope, advanced heart failure treatment system and other devices were among a group of products granted pass-through payments for 2021 by the Centers for Medicare and Medicaid Services in a recent final rule.
The medtech products were approved by CMS as part of its annual program to promote access to new and innovative devices, while collecting necessary cost data to evaluate their long-term...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
